DD209828A5 - Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen - Google Patents

Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen Download PDF

Info

Publication number
DD209828A5
DD209828A5 DD83250744A DD25074483A DD209828A5 DD 209828 A5 DD209828 A5 DD 209828A5 DD 83250744 A DD83250744 A DD 83250744A DD 25074483 A DD25074483 A DD 25074483A DD 209828 A5 DD209828 A5 DD 209828A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
alkyl
meaning
item
nhr
Prior art date
Application number
DD83250744A
Other languages
German (de)
English (en)
Inventor
John L Lamattina
Christopher A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD209828A5 publication Critical patent/DD209828A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Lubricants (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Cephalosporin Compounds (AREA)
DD83250744A 1982-05-10 1983-05-09 Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen DD209828A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Publications (1)

Publication Number Publication Date
DD209828A5 true DD209828A5 (de) 1984-05-23

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83250744A DD209828A5 (de) 1982-05-10 1983-05-09 Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen

Country Status (26)

Country Link
US (1) US4435396A (fr)
EP (1) EP0094191B1 (fr)
JP (1) JPS58206588A (fr)
KR (1) KR860000931B1 (fr)
AT (1) ATE33649T1 (fr)
AU (2) AU539244B2 (fr)
CA (1) CA1201120A (fr)
CS (1) CS252461B2 (fr)
DD (1) DD209828A5 (fr)
DE (1) DE3376322D1 (fr)
DK (1) DK163829B (fr)
EG (1) EG17029A (fr)
ES (1) ES8407045A1 (fr)
FI (1) FI78481C (fr)
GR (1) GR79279B (fr)
GT (1) GT198302123A (fr)
HU (2) HU196377B (fr)
IE (1) IE55229B1 (fr)
IL (1) IL68630A (fr)
NO (1) NO159932C (fr)
NZ (1) NZ204158A (fr)
PL (1) PL141199B1 (fr)
PT (1) PT76662B (fr)
SU (1) SU1195907A3 (fr)
YU (1) YU42857B (fr)
ZA (1) ZA833286B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (fr) * 1986-08-29 1991-08-21 Pfizer Inc. Guanidino-2 aryl-4 thiazole pour le traitement de l'ulcère peptique
ES2054684T3 (es) * 1986-10-29 1994-08-16 Pfizer Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo.
WO1994028898A1 (fr) * 1993-06-15 1994-12-22 Pfizer Inc. Antagonistes d'h2 utilises comme stimulants immunitaires pour traiter des infections bacteriennes chez le betail ou les cochons
US8536185B2 (en) 2008-09-22 2013-09-17 Cayman Chemical Company, Incorporated Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
WO2022034121A1 (fr) 2020-08-11 2022-02-17 Université De Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
ATE33649T1 (de) 1988-05-15
KR860000931B1 (ko) 1986-07-19
PL141199B1 (en) 1987-07-31
CA1201120A (fr) 1986-02-25
AU539244B2 (en) 1984-09-20
YU99683A (en) 1986-02-28
PL241840A1 (en) 1985-01-16
YU42857B (en) 1988-12-31
JPS58206588A (ja) 1983-12-01
CS318483A2 (en) 1987-02-12
IE831061L (en) 1983-11-10
DE3376322D1 (en) 1988-05-26
IL68630A0 (en) 1983-09-30
HU190899B (en) 1986-12-28
AU3081584A (en) 1984-11-08
FI831595L (fi) 1983-11-11
NO159932C (no) 1989-02-22
IE55229B1 (en) 1990-07-04
NO159932B (no) 1988-11-14
AU566755B2 (en) 1987-10-29
DK163829B (da) 1992-04-06
EG17029A (en) 1992-06-30
ES522223A0 (es) 1984-08-16
EP0094191B1 (fr) 1988-04-20
KR840004745A (ko) 1984-10-24
NO831632L (no) 1983-11-11
PT76662A (en) 1983-06-01
AU1436383A (en) 1983-11-17
IL68630A (en) 1987-03-31
SU1195907A3 (ru) 1985-11-30
DK205883D0 (da) 1983-05-09
FI78481B (fi) 1989-04-28
DK205883A (da) 1983-11-11
GR79279B (fr) 1984-10-22
ZA833286B (en) 1984-12-24
HU196377B (en) 1988-11-28
FI78481C (fi) 1989-08-10
ES8407045A1 (es) 1984-08-16
FI831595A0 (fi) 1983-05-09
EP0094191A1 (fr) 1983-11-16
PT76662B (en) 1986-04-16
GT198302123A (es) 1984-10-27
NZ204158A (en) 1986-05-09
CS252461B2 (en) 1987-09-17
US4435396A (en) 1984-03-06

Similar Documents

Publication Publication Date Title
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DD233374A5 (de) Verfahren zur herstellung von 2-(n-subst.-guanidino)-4-heteroarylthiazole
CH652395A5 (de) 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen.
DD201893A5 (de) Verfahren zur herstellung von neuen imidazolyphenyl-amidinen
DD209828A5 (de) Verfahren zur herstellung von 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazolen
DD202293A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DE2847622A1 (de) Neue chinazolin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE19824175A1 (de) Amino-azol-Verbindungen
DE2847792C2 (fr)
DD265403A5 (de) Verfahren zum herstellen herzstimulierender chinolene
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE10036818A1 (de) Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE2800316A1 (de) Oximether enthaltende arzneimittel zur bekaempfung von ulcera, oximether und verfahren zu ihrer herstellung
DD258608A1 (de) Verfahren zur herstellung neuer thieno(2,3-alpha)-imidazolderivate
CH645368A5 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
DE2832309C2 (fr)
EP0138034B1 (fr) Pyrido[1,2-c]imidazo[1,2-a]benzimidazoles substitués, procédé pour leur préparation, leur application et compositions pharmaceutiques à base de ces composés
DE1921049A1 (de) Neue organische Verbindungen und Verfahren zu ihrer Herstellung
EP0110298B1 (fr) Dérivés d'acridanone
DE2247187A1 (de) Imidazolylessigsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3413875A1 (de) Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
DE2313256B2 (de) 1 ^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0266532A1 (fr) Sels d'imidazolium disubstitués 1,3

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee